USFDA gives nod to Pfizer’s drug therapy for patients with Hemophilia – Healthcare News
The U.S. Food and Drug Administration (USFDA) approved Hympavzi (marstacimab-hncq) for patients suffering from Hemophilia A or B. According to...
The U.S. Food and Drug Administration (USFDA) approved Hympavzi (marstacimab-hncq) for patients suffering from Hemophilia A or B. According to...
A new study by researchers at The Ohio State University Wexner Medical Center, College of Medicine, and College of Nursing proves the mood-boosting benefits of...
Sun Pharmaceutical Industries Limited on Friday announced that it has launched Tedizolid Phosphate tablets 200 mg in India under the...
The status of mental health is bleak. The latest data reveals that mental health is neglected or unavailable in many...
Varanasi: The Trauma Centre of Banaras Hindu University (BHU) has introduced Hyperbaric Oxygen Therapy (HBOT) to enhance treatment for trauma...
Attendees will benefit from expedited shortlisting processes, personal engagement with recruiters, and valuable networking opportunities Published: Wed 3 Jul 2024,...
29-year-old Rishika* is feeling better now. However, she believes there is always a scope of improvement. “…periodic fine-tuning is always...
There are currently no marketed disease-modifying therapies (DMTs) for Parkinson’s disease (PD). At the American Academy of Neurology (AAN) 2024...
Submitted Photo CaringEdge Home Health staff are shown. Front row: Jayda, office companion dog; Megan Ruff-Buchmeier, RN...